This lawsuit is for anyone who acquired securities in Integra LifeSciences Holdings Corporation (NASDAQ: IART) from March 11, 2019 through May 22, 2023.
The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, lawsuit alleges that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company misled investors by telling investors that the Company had controls over its manufacturing but then by producing products with with higher levels of endotoxins than permitted by the product specifications.
On May 23, 2023, Integra disclosed that it had initiated a recall of its SurgiMed, PriMatrix, Revize, and TissueMend products manufactured at its Boston facility as far back as March 1, 2018. The Company attributed the recall to a finding that products may have been distributed with higher levels of endotoxins than permitted by the product specifications. As a result, the Company expects to write off approximately $22 million in inventory. On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.
The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Integra LifeSciences Holdings Corporation (NASDAQ: IART) from March 11, 2019 through May 22, 2023 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.
3070 Bristol Pike, Suite 112, Bensalem, PA 19020 
View Complaint
hsmith@howardsmithlaw.com